On Tuesday, Agios Pharmaceuticals Inc (NASDAQ: AGIO) was 4.17% up from the session before settling in for the closing price of $44.83. A 52-week range for AGIO has been $20.40 – $53.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2.66% over the last five years. When this article was written, the company’s average yearly earnings per share was at 281.41%. With a float of $55.28 million, this company’s outstanding shares have now reached $55.95 million.
The firm has a total of 383 workers. Let’s measure their productivity. In terms of profitability, gross margin is 76.16%, operating margin of -1238.1%, and the pretax margin is 2212.98%.
Agios Pharmaceuticals Inc (AGIO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Agios Pharmaceuticals Inc stocks. The insider ownership of Agios Pharmaceuticals Inc is 3.06%, while institutional ownership is 101.24%. The most recent insider transaction that took place on Sep 26 ’24, was worth 124,634. In this transaction Chief Financial Officer of this company sold 2,542 shares at a rate of $49.03, taking the stock ownership to the 20,158 shares. Before that another transaction happened on Aug 08 ’24, when Company’s Chief Executive Officer sold 11,091 for $42.75, making the entire transaction worth $474,140. This insider now owns 78,792 shares in total.
Agios Pharmaceuticals Inc (AGIO) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.72 earnings per share (EPS) during the time that was less than consensus figure (set at -1.65) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.63 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 281.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.00% during the next five years compared to -0.98% drop over the previous five years of trading.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
You can see what Agios Pharmaceuticals Inc (AGIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 81.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.37, a number that is poised to hit -1.68 in the next quarter and is forecasted to reach -6.08 in one year’s time.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
Analysing the last 5-days average volume posted by the [Agios Pharmaceuticals Inc, AGIO], we can find that recorded value of 0.66 million was lower than the volume posted last year of 0.69 million. As of the previous 9 days, the stock’s Stochastic %D was 55.26%. Additionally, its Average True Range was 1.83.
During the past 100 days, Agios Pharmaceuticals Inc’s (AGIO) raw stochastic average was set at 50.66%, which indicates a significant decrease from 87.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.49% in the past 14 days, which was lower than the 38.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.61, while its 200-day Moving Average is $38.15. Now, the first resistance to watch is $47.91. This is followed by the second major resistance level at $49.12. The third major resistance level sits at $51.45. If the price goes on to break the first support level at $44.37, it is likely to go to the next support level at $42.04. Now, if the price goes above the second support level, the third support stands at $40.83.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Key Stats
There are 57,030K outstanding shares of the company, which has a market capitalization of 2.66 billion. As of now, sales total 26,820 K while income totals -352,090 K. Its latest quarter income was 8,960 K while its last quarter net income were 947,920 K.
